Seroprevalence of measles IgM in children 5-12 years from selected primary schools in Giwa Local Government Area, Zaria, Kaduna state
Keywords:
Measles, ELISA, SeroprevalanceAbstract
Seroprevalence of Measles IgM was carried out among children age 5-12 years in Giwa, Kaduna State. The test was carried out using Enzyme Linked Immunosorbent Assay (ELISA) method. Of the 90 (100%) samples assayed for the measles IgM antibodies, 32.2% were seropositive for measles IgM. A breakdown of the seropositive subject reveals that 18.9% of the infected children were males, while 13.3% were females. Those children within the age of 5-6years had the highest prevalence (16.6%), followed by those within the age of 7-8years (6.6), 9-10years and 11-12years had 5.5% and 3.3% respectively. However, in relation to sex the male children had the highest prevalence of 38% while the female children had a prevalence of 26%. It was observed that 16 (17 8%) of the children had fever and of these number, 68.75% tested positive for measles. However, rashes were most associated with measles in the studies as all the children with rashes were positive for measles IgM. The study also revealed that only 7.7% of the immunized children tested positive for measles IgM.
References
Adu, F.D., Adeniji, J.A., 1995. Measles antibodies in the breast milk of nursing mothers, Afr. J. Med. Med. Sci.,
,385-88.
Bassey, E.B., Moses, A.E., Udo, S.U., Umo, A.N., 2010. The impact of immunization control activities on measles in
Akwa Ibom State. Online J. Health All. Sci., 9(1),3 – 8.
Brown, P., 2000. A plan to reduce measles deaths. Nat. Med., 6(12), 1305 – 1307.
FGN/ WHO., 1996. Emergency preparedness and response to epidermic April, Pp. 29.
Griffin, D., 2007. Measles Virus. In, Martin, Malcolm, A., Knipe, David, M., Fields, Bernard, N., Howley, Peter, M.,
Lamb and Robert (eds). Fields' Virology (5th ed.). Philadelphia, Wolters Kluwer Health/Lippincott Williams &
Wilkins.
Harminder, S., Ahmad, M.O., Arun, D., Singh., 2008. Abu Bakr Razi. Brit. J. Ophthalmol., 92,1324 – 1328.
Manirakiza, A., Kipela, J.M., Sosler, S., Daba, R.M., Gouandjika-Vasilache, I., 2011. Seroprevalence of Measles and
Natural Rubella Antibodies among children in Bangui, Central African Republ. BMC Publ. Health., 11, 327 –
Nigatu, W., Nokes, D.J., Cohen, B.J., Brown, D.W.G., Vyse, A.J., 2003. Pre-and Post-vaccine Measles Antibody Status
in infants using serum and oral-fluid testing, An Evaluation of routine immunization in Addis Ababa, Ethiopia
Ethiop. J. Health Dev., 17(3), 149-155.
Offit, P.A., 2007. Vaccinated, One Man's Quest to Defeat the World's Deadliest Diseases. Washington, DC,
Smithsonian, Pp 11-14.
Onoja, A.L, Adu, F.D., Tomori, O., 1992. Evaluation of measles vaccination programme conducted in two separate
centers. Vacc., 10, 49-52.
Perry, R.T., Halsey, N.A., 2004. The Clinical Significance of Measles, a review. J. Infect. Dis., 1,S4-S16.
Schneider, S., Schneider, J., 2009. Measles virus-induced immunosuppression. Trop. Microbiol. Immunol., 330,243-
Smeeth, L., Cook, C., Fombonne, E., 2004. MMR Vaccination and Pervasive Developmental Disorders, a casecontrol study. Lancet., 364(9438), 963-969.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2014 J. Chechet, E. E. Ella, S. O. Ige
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
